Table 3.
In-hospital reperfusion and revascularisation strategies in the study patients
| Characteristics | Total (n=1799) | STEMI/new LBBB (n=463) | UA/NSTEMI (n=1336) | p Value |
|---|---|---|---|---|
| Reperfusion strategies, n (%) | ||||
| No reperfusion | – | 153 (33.6) | – | – |
| Primary CABG | – | 13 (2.9) | – | – |
| Thrombolytic therapy | – | 211 (46.3) | – | – |
| Symptom onset to thrombolytic | – | 269.0±477.3 | – | – |
| Door-to-needle time | – | 45.6±41.1 | – | – |
| Primary PCI | – | 79 (17.3) | – | – |
| Symptom onset to PCI | – | 256.8±186.6 | – | – |
| Door-to-balloon time | – | 82.8±112.5 | – | – |
| Revascularisation strategies, n (%) | ||||
| Coronary angiography | 1232 (68.5) | 368 (79.5) | 864 (64.7) | <0.0001 |
| PCI (excluding primary PCI) | 360 (20.0) | 133 (28.7) | 227 (17.0) | <0.0001 |
| DES | 258 (71.9) | 94 (70.1) | 164 (72.9) | 0.764 |
| BMS | 81 (22.6) | 33 (24.6) | 48 (21.3) | |
| Both | 20 (5.5) | 7 (5.2) | 13 (5.8) | |
| CABG surgery | 180 (10.0) | 34 (7.3) | 146 (10.9) | 0.049 |
All plus-minus values are mean±SD.
BMS, bare metal stent; CABG, coronary artery bypass grafting surgery; DES, drug-eluting stent; LBBB, left bundle branch block; NSTEMI, non-ST-segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; UA, unstable angina.